Company / Cost of Revenue
Bionano Genomics, Inc. Cost of Revenue History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$15.3M
FY2025
5-year range
$14.1M / $30.4M
FY2021-FY2025
Trend
-49.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $27M to $15M over the past 2 years.
Based on SEC 10-K filings.
$15M in FY2025 with a 5-year CAGR of +21.7%.
Improved from $27M to $15M over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -11.2%
- 5-Year CAGR
- +21.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +21.7%, indicating consistent growth.
- In FY2025, cost of revenue decreased 49.6% year-over-year.
- Peak cost of revenue was recorded in FY2024.
- Lowest cost of revenue in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -8.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.3M | -49.6% |
| FY2024 | $30.4M | +14.5% |
| FY2023 | $26.6M | +21.5% |
| FY2022 | $21.9M | +54.9% |
| FY2021 | $14.1M | +146.2% |
| FY2020 | $5.7M | -15.3% |
| FY2019 | $6.8M | -22.3% |
| FY2018 | $8.7M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 22, 2026